Termination TerugBetaalRegeling Tecfidera®
As of December 1, 2021, a Personal Contribution for Tecfidera is no longer required. Health insurers will once again fully...
Termination TerugBetaalRegeling Fragmin®2500
From January 1st 2022 onwards, the reimbursement scheme for FRAGMIN (dalteparine)2500 INJVLST 12.500IE/ML WWSP 0,2ML will be...
Reimbursement Scheme Forxiga® (dapagliflozin) 10 mg for patients with diabetes partially stopped
From September 1st 2021 onwards, Forxiga® (dapagliflozin) 10 mg for the treatment of adults with type 2 diabetes mellitus with a...
Reimbursement Scheme Forxiga® (dapagliflozine) 10 mg - Chronic Kidney Disease
The health insurer does not yet fully reimburse Forxiga® (dapagliflozine) 10 mg for the treatment of chronic kidney disease...
Termination TerugBetaalRegeling Forxiga® - Hartfalen
From July 1st 2021 onwards, Forxiga® (dapagliflozine) 10 mg for the treatment of heart failure with reduced ejection fraction...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine